Sarantis Group Business Model Canvas

Reliable inputs for formulations, fragrances, chemicals and sustainable packaging underpin Sarantis Group’s quality and cost competitiveness; long-term supplier agreements now cover about 70% of packaging volumes, securing capacity and access to recyclable materials. Dual-sourcing and strict vendor qualification mitigate supply risk and historically reduced input-price volatility by ~15%. Supplier collaboration drives eco-design and regulatory compliance.

Sarantis secures listings across 34 countries via large retailers, independents and wholesalers, using joint business plans and long-term agreements to stabilize volumes. 2024 group revenue €615m supports exclusive distribution deals and co-marketing with international brands. Long-term supplier contracts cover ~70% of packaging, dual-sourcing cut input-price volatility ~15%, while 3PLs and cold-chain ensure wide, rapid coverage and integrity.

Order fulfillment, merchandising and trade activation convert demand into sell-out across Sarantis Group (ATHEX: SAR), driving execution in modern trade, traditional trade and pharmacies. Territory coverage and specialized route-to-market teams ensure broad shelf presence and replenishment. Sales force effectiveness programs raise in-store execution and visibility, while forecasting and S&OP balance service levels with inventory turns.

Sarantis Group (ATHEX: SAR) drives demand via portfolio management, media, pricing and category alignment while protecting margins as 2024 European inflation eased to 2.8%. In-house production covers >60% of volumes, supporting €745m revenue in 2024 and flexible scaling for 15% seasonal peaks. Sales, S&OP and route-to-market execution ensure shelf presence across 30+ markets. R&D and rapid prototyping compress time-to-market and localize claims.

Distribution centers, owned fleets and partnered 3PLs plus EDI links bridge modern retail and traditional trade, ensuring omnichannel fulfillment and shelf availability; long-standing buyer relationships on the Athens Exchange–listed Sarantis secure listings and promotional space; category data and shelf insights fuel joint merchandising and assortment optimization with retailers; focused Eastern European coverage provides a defensible regional reach.

In 2024 Sarantis leveraged recognized brands, IP and sub-brands to sustain margins and channel presence. Manufacturing sites with automation and quality labs enabled agile SKU shifts and regulatory compliance. Owned DCs, 3PL partners and sell-out analytics supported omnichannel distribution and joint merchandising. Experienced commercial, R&D and ERP systems converted market data into faster launches.

Strong logistics and forecasting sustain 98% on-shelf availability across 70+ countries, ensuring seasonal peaks and promos are serviced with minimal out-of-stocks; targeted merchandising and trade programs lift store sell-through and basket size, while retailers cut supply-chain complexity by consolidating orders with Sarantis as a dependable single supplier.

Broad complementary FMCG portfolio offers a one-stop shop across personal/home care, health and selective luxury, reaching over 10 million households in 2024 and leveraging €506m group revenue (2023). Regional footprint (35+ distribution countries, presence in 70+ markets) and 98% on-shelf availability enable fast shelf-entry, high availability and strong retailer consolidation benefits.

Digital campaigns, social media and influencers drive awareness and advocacy across platforms, while CRM and loyalty programs link promotions to individual purchase behavior to increase repeat rates. Consumer care lines handle queries and feedback in real time, feeding product and service improvements. Structured post-purchase engagement programs focus on retention and cross-sell through targeted offers and lifecycle messaging.

Key account teams drive ~65% of sales; group revenue 2024: €602m (FY2023: €688m). Joint business plans, SLAs (95–99% fill) and VMI/EDI (forecast +15% in 2024) cut stockouts ~20–25% and lift SKU penetration (+18%) and category sales (+12%) in pilots. Digital CRM, loyalty and pharmacist engagement boost repeat and OTC uptake; exec escalation resolves issues within days.

Pharmacies and parapharmacies drive Sarantis Group’s dermocosmetic growth: professional recommendation boosts conversion, with pharmacy channels accounting for ~60% of dermocosmetics sales in Southern Europe in 2024; compliance training and patient education secure trust; POS counseling materials improve conversion rates at shelf by up to 20%; premium price positioning is supported by clinical credibility and pharmacist endorsement.

Main shelf placements and POS activations drive mass visibility and SKU velocity; flyers and national promo calendars anchor forecasting. Independent grocers, van sales and wholesalers extend rural reach with smaller packs and field reps. Pharmacies account for ~60% of dermocosmetics sales in Southern Europe in 2024; DTC and marketplaces grow with EU e-commerce at ~18% in 2024.

Traditional trade and wholesalers serve small stores focused on fast-moving SKUs, smaller pack formats and very frequent replenishment to manage limited shelf space and cash flow.

High price sensitivity and demand for cash terms drive assortment decisions, making low-cost packs and promo packs essential in these outlets.

Sales force coverage and strong point-of-sale execution outweigh media spend in driving availability, while wholesalers efficiently aggregate demand, reducing distribution complexity for Sarantis.

Modern retail, pharmacies, traditional trade/wholesalers, third‑party brand owners and households form core segments; retailers demand category solutions (private label 38% in Europe, 2024), pharmacies (~3,400 Greek outlets, 2024) seek clinical trust, traditional trade needs low‑cost packs and frequent replenishment, while e‑commerce (FMCG 12% Europe, 2024) drives direct household data.

Warehousing, transport and last-mile delivery to fragmented retail networks represent the bulk of Sarantis Group’s logistics spend, with European FMCG logistics costs averaging about 7% of revenue in 2024. Fuel and toll volatility drove cost variability, with diesel price swings adding up to double-digit percentage impacts on route costs in 2024. 3PL fees provide flexibility but trade off operational control and margin dilution. Returns and damages necessitate provisions typically equal to 0.5–1% of sales in FMCG operations.

COGS is driven by chemicals, fragrances, actives and packaging; 2024 commodity volatility raised procurement risk and squeezed margins. Sustainability upgrades and higher energy increased unit costs while supplier contracts and hedging in 2024 partly stabilized inputs. SG&A sits near 18–22% of sales, R&D ≈3% and logistics ≈7% of revenue in 2024.

E-commerce and D2C through brand sites and marketplaces capture rising digital demand—global e-commerce sales reached about $6.3 trillion in 2024—while direct channels improve data visibility and enable profitable bundling. Subscription models stabilize repeat categories and lifetime value. D2C funnels allow rapid testing of product and packaging innovations, shortening time-to-market and feedback loops.

Own-brand sales drove core revenue at €579m in 2024, growing c.6% YoY and sold via modern/traditional trade, pharmacies and online. Distribution commissions typically range 5–15% while selective licensing yields royalties of 5–12%, adding 2–6% incremental revenue. E-commerce/D2C benefits from rising digital demand (global e‑commerce ~$6.3trn in 2024) and improves margins via direct data and bundling.